-
cds.ahrq.gov/sites/default/files/workgroups/143366/CDS_Connect_WG_April_2022_Presentation.pdf
January 01, 2022 - April 2022 CDS Connect Work Group Call
April 2022 CDS Connect Work Group Call
Agenda
Schedule Topic
3:00 – 3:02 Roll Call, Michelle Lenox (MITRE)
3:02 – 3:05 Review of the Agenda, Maria Michaels (CDC)
3:05 - 3:35 Roundtable and Discussion on Partnering Experience:
Amy Price (Stanford); Danny van Leeuwen (Hea…
-
cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2021.pdf
January 01, 2021 - The team’s criteria for considering
updates included consideration of new
relevant professional guideline … Patient-Facing CDS Intervention
No Yes Yes Yes
5 Occupational Factors Impacting Diabetes is under consideration … The WG has engaged
throughout key project phases, from
consideration of high-level desired outcomes … • Tracking stakeholder
recommendations for consideration
in future sprints.
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/2024_CDS_Connect_IG_Pain_Management_Summary.pdf
January 01, 2024 - Pain Management
Successful treatment of chronic pain requires consideration of the patient’s previous … provide information on use of the CDS artifact to provide patient-centered care and other areas
of consideration … Treatment requires
the consideration of multiple factors, such as psychiatric comorbidity (e.g., depression
-
cds.ahrq.gov/sites/default/files/workgroups/216/jan-2017-cholesterol-wg-notes.docx
January 01, 2017 - Cholesterol Management Work Group
Meeting Summary
Date
01/11/2017
Time
3:00 – 5:00 PM ET
AGENDA
· Welcome and introductions
· Discuss ACC/AHA 10-Year ASCVD Risk Assessment Tool Metadata and CDS creation
· Discuss Longitudinal Risk Assessment Tool Metadata, CDS Creation and Shared Decision Making
· Questions to…
-
cds.ahrq.gov/sites/default/files/cds/artifact/1146/Warfarin-Antidepressants%20MDIA%20Implementation%20Guide.docx
August 29, 2020 - are often simplistic in nature or do not take the specific patient and pharmacological contexts into consideration
-
cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax%20Post%20Exposure%20Prophylaxis%20Implementation%20Guide%20v2.0%2020190607.pdf
June 07, 2019 - Prevention and
Treatment of Anthrax in Adults: Technical Report, Table
1 provides a detailed list for consideration
-
cds.ahrq.gov/sites/default/files/cds/artifact/26/2024_CDS_Connect_IG_Aspirin_Therapy.pdf
January 01, 2024 - It provides a
USPSTF Grade C recommendation for consideration by clinicians and their patients to support … full recommendation statement, insight provided by the Cholesterol Management Work
Group, and careful consideration
-
cds.ahrq.gov/sites/default/files/workgroups/231/apr-2017-cholesterol-wg-notes.docx
January 01, 2017 - Cholesterol Management Work Group
Meeting Summary
Date
04/19/2017
Time
01:00 – 3:00 PM EST
AGENDA
· Welcome
· Brief Overview of Existing CDS Connect Artifacts
· Clarify Logic Details for USPTF-related Artifacts
· Discuss Best Approach for Transforming eCQM Specifications into CDS Logic
· Next Steps an…
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/CDSConnectPilotFinalReport508gel10012018.pdf
September 01, 2018 - CDS Connect Pilot Final Report Factors to Consider in Managing Chronic Pain: A Pain Management Summary
CDS Connect Pilot Final Report
Factors to Consider in Managing Chronic Pain:
A Pain Management Summary
Prepared for:
Agency for Healthcare Research and…
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
January 01, 2024 - a patient who might benefit is identified, the CDS
presents an alert to the clinician that prompts consideration
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Pilot%20Report_Final_0.docx
March 01, 2018 - had the opportunity to interview clinicians regarding their workflow related to patient assessment in consideration … Weekly checks on the number of patients exposed to the CDS were performed, and there was consideration
-
cds.ahrq.gov/sites/default/files/cds/artifact/171/Occupational%20Factors%20which%20Impact%20Diabetes,%20%20A%20Final%20Knowledge%20Resource%20Report%20(2015).pdf
January 01, 2015 - treated with insulin or
oral agents with a risk for hypoglycemia must be individualized, taking into consideration … more than one accommodation will be effective, the employee's preference should be given
primary consideration … treated with insulin or oral agents
with a risk for hypoglycemia must be individualized, taking into consideration
-
cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM_Final.docx
October 01, 2017 - CDS Connect Implementation Guide Draft
Implementation Guide
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease Electronic Clinical Quality Measure
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
5600 Fishers Lane
Rockville, MD 20857
www.ahrq…
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/EnhancementofCDSArtifact%20BasedonPilotImplementation10012018.pdf
December 01, 2018 - CDS Artifact Enhancement Based on Pilot Implementation. Factors to Consider in Managing Chronic Pain:
CDS Artifact Enhancement Based on Pilot
Implementation
Factors to Consider in Managing Chronic Pain:
A Pain Management Summary
Prepared for:
Ag…
-
cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation_Guide_CMS_Million_Hearts_ASCVD_Risk_Assessment.pdf
September 01, 2021 - CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk
1
Implementation Guide
CMS’s Million Hearts® Model Longitudinal ASCVD
Risk Assessment Tool for Baseline 10-Year
ASCVD Risk
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857 …
-
cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation%20Guide_CMS%20Million%20Hearts_ASCVD%20Risk%20Assessment_Level3_Final.pdf
February 01, 2018 - CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk
Implementation Guide
CMS’s Million Hearts® Model Longitudinal
ASCVD Risk Assessment Tool for Baseline 10-
Year ASCVD Risk
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Hu…
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - Additional preferred characteristics of a pilot organization were also identified as important for
consideration
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - Additional preferred characteristics of a pilot organization were also identified as important for
consideration
-
cds.ahrq.gov/sites/default/files/cds/artifact/1066/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - Additional preferred characteristics of a pilot organization were also identified as important for
consideration
-
cds.ahrq.gov/sites/default/files/cds/artifact/1071/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
September 01, 2019 - Additional preferred characteristics of a pilot organization were also identified as important for
consideration